Functional P-glycoprotein (PGP) and wild-type (WT) P53 activity are not associated with response to chemotherapy in childhood acute myelogenous leukemia (AML)

被引：0
|
作者：
Ivy, SP [1 ]
Gudas, JM [1 ]
Taylor, B [1 ]
Chhabra, A [1 ]
Li, T [1 ]
Cowan, KH [1 ]
机构：
[1] CHILDRENS NATL MED CTR,CHILDRENS RES INST,CTR CANC & TRANSPLANTAT BIOL,WASHINGTON,DC 20010
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：923 / 923
页数：1
相关论文
共 50 条
  • [21] Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
    Trinidad, Antonio Garcia
    Muller, Patricia A. J.
    Cuellar, Jorge
    Klejnot, Marta
    Nobis, Max
    Maria Valpuesta, Jose
    Vousden, Karen H.
    MOLECULAR CELL, 2013, 50 (06) : 805 - 817
  • [22] Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia
    Tsuji, Kazue
    Wang, Yan-Hua
    Takanashi, Minoko
    Odajima, Tsuyoshi
    Lee, Gabriel. A.
    Sugimori, Hiroki
    Motoji, Toshiko
    HEMATOLOGY REPORTS, 2012, 4 (03) : 56 - 59
  • [23] Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    Atencio, IA
    Avanzini, JB
    Johnson, D
    Neuteboom, S
    Vaillancourt, MT
    Nielsen, LL
    Hajian, G
    Sutjipto, S
    Sugarman, BJ
    Philopena, J
    McAllister, DL
    Beltran, JC
    Nodelman, M
    Ramachandra, M
    Wills, KN
    MOLECULAR THERAPY, 2001, 4 (01) : 5 - 12
  • [24] DISSECTING THE FUNCTIONAL IMPAIRMENT OF WILD-TYPE P53 IN HUMAN GLIOBLASTOMA
    Garcia-Montano, Leopoldo A.
    Munoz, Yamhilette Licon
    Martinez, Frank
    Gallegos, Kandee
    Bowers, Christian A.
    Kang, Huining
    Piccirillo, Sara G. M.
    NEURO-ONCOLOGY, 2024, 26
  • [25] P-glycoprotein mediated multidrug resistance phenotype in de novo adult acute myelogenous leukemia (AML).
    Machaczka, M
    Rucinska, M
    Balana-Nowak, A
    Zaluska, A
    Zdzilowska, E
    Jurczak, W
    Wolska-Smolen, T
    Wegrzyn, J
    Nowak, WS
    Skotnicki, AB
    BLOOD, 1999, 94 (10) : 194B - 194B
  • [26] p53 gene status predicts response of epithelial cells to wild-type p53.
    St John, LS
    Sauter, ER
    Herlyn, M
    Litwin, S
    Alder-Storthz, K
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 167 - 167
  • [27] DNA binding distinguishes wild-type and mutant p53 activity
    Ray, Debolina
    Gal, Susannah
    CANCER RESEARCH, 2010, 70
  • [28] Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
    Van Maerken, Tom
    Rihani, Ali
    Van Goethem, Alan
    De Paepe, Anne
    Speleman, Frank
    Vandesompele, Jo
    CANCER LETTERS, 2014, 344 (02) : 157 - 165
  • [29] Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
    Sugrue, MM
    Shin, DY
    Lee, SW
    Aaronson, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) : 9648 - 9653
  • [30] Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
    Lisa S St. John
    Edward R Sauter
    Meenhard Herlyn
    Samuel Litwin
    Karen Adler-Storthz
    Cancer Gene Therapy, 2000, 7 : 749 - 756
12345